| CTRI Number |
CTRI/2024/05/067206 [Registered on: 10/05/2024] Trial Registered Prospectively |
| Last Modified On: |
13/01/2026 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Ayurvedic management for Carpal Tunnel Syndrome - A randomized pilot clinical trial. |
|
Scientific Title of Study
|
A comparative analysis of Agnikarma and Siravyadha in the management of Carpal Tunnel Syndrome - – A randomized pilot clinical trial. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Pratap Shankar K M |
| Designation |
Research Officer (Ay.) |
| Affiliation |
National Ayurveda Research Institute for Panchakarma |
| Address |
Room no. 621, Department of Ayurveda, National Ayurveda Research Institute for Panchakarma
Thrissur KERALA 679531 India |
| Phone |
9744824014 |
| Fax |
|
| Email |
kmpvarma@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Pratap Shankar K M |
| Designation |
Research Officer (Ay.) |
| Affiliation |
National Ayurveda Research Institute for Panchakarma |
| Address |
Room no. 621, Department of Ayurveda, National Ayurveda Research Institute for Panchakarma
KERALA 679531 India |
| Phone |
9744824014 |
| Fax |
|
| Email |
kmpvarma@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Pratap Shankar K M |
| Designation |
Research Officer (Ay.) |
| Affiliation |
National Ayurveda Research Institute for Panchakarma |
| Address |
Room no. 621, Department of Ayurveda, National Ayurveda Research Institute for Panchakarma
KERALA 679531 India |
| Phone |
9744824014 |
| Fax |
|
| Email |
kmpvarma@gmail.com |
|
|
Source of Monetary or Material Support
|
| National Ayurveda Research Institute for Panchakarma, Cheruthuruthy, Thrissur, Kerala - 679531, India |
|
|
Primary Sponsor
|
| Name |
Central Council for Research in Ayurvedic Sciences |
| Address |
Janakpuri, New Delhi 110058 (India) |
| Type of Sponsor |
Research institution |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Pratap Shankar K M |
National Ayurveda Research Institute for Panchakarma |
Room no. 621, Department of Ayurveda, Cheruthuruthy Thrissur KERALA |
9744824014
kmpvarma@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| National Ayurveda Research Institute for Panchakarma |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:G560||Carpal tunnel syndrome. Ayurveda Condition: SNAYUGATAVATAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | agnikarma, अगà¥à¤¨à¤¿à¤•रà¥à¤® | (Procedure Reference: Susrutha Samhita Chikitsa Sthana 1/8, Procedure details: Agnikarma (with Pancha lohasalaka) over the plantar aspect of the wrist of the affected hand. Bindu type of agnikarma will be done from the radial border to the ulnar border, extending one finger above & below the wrist crease.
Two sittings with an interval of 15 days)
| | 2 | Comparator Arm | Procedure | - | sirAvedhaH, सिरावेधः | (Procedure Reference: Astanga Hrdayam Sutra Sthanam 27/16, Procedure details: Sirvyadana – vein near the cubital fossa (cephalic vein) will be punctured.
Two sittings with an interval of 15 days Volume – 40 to 60 ml)
|
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Clinically diagnosed mild to moderate CTS and confirmed through NCS |
|
| ExclusionCriteria |
| Details |
1. Patients with uncontrolled diabetes, hypothyroidism and rheumatoid arthritis.
2. Pregnant ladies
3. Patients previously operated for CTS
4. Patients with other types of neuropathies, inflammatory arthritis, soft tissue rheumatism, post trauma or wrist surgery |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Changes in symptom severity and functional severity scale score (BCTQ) |
1 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Changes in Phalen’s maneuver test and Tinel’s sign |
1 month |
|
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
22/05/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Closed to Recruitment of Participants |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Statistical Analysis Plan Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [kmpvarma@gmail.com].
- For how long will this data be available start date provided 01-04-2025 and end date provided 01-04-2031?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - Nil
|
|
Brief Summary
|
To compare the effectiveness
of Agnikarma and Siravyadha in reducing CTS symptoms and improving functional
status in patients with mild-to-moderate CTS. |